A real‐world study of alemtuzumab in a cohort of Italian patients

BACKGROUND AND PURPOSE: Real‐world data on alemtuzumab are limited and do not provide evidence of its effectiveness after various disease‐modifying therapies (DMTs). Our aim was to provide real‐world data on the impact of clinical variables and previous DMTs on clinical response to alemtuzumab. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Russo, Cinzia Valeria, Saccà, Francesco, Frau, Jessica, Annovazzi, Pietro, Signoriello, Elisabetta, Bonavita, Simona, Grasso, Roberta, Clerico, Marinella, Cordioli, Cinzia, Laroni, Alice, Capobianco, Marco, Torri Clerici, Valentina, Sartori, Arianna, Cavalla, Paola, Maniscalco, Giorgia Teresa, La Gioia, Sara, Caleri, Francesca, Giugno, Alessia, Iodice, Rosa, Carotenuto, Antonio, Cocco, Eleonora, Fenu, Giuseppe, Zaffaroni, Mauro, Baroncini, Damiano, Lus, Giacomo, Gallo, Antonio, De Mercanti, Stefania Federica, Lapucci, Caterina, Di Francescantonio, Valeria, Brambilla, Laura, Sormani, Maria Pia, Signori, Alessio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Multiple Sclerosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293282/
https://www.ncbi.nlm.nih.gov/pubmed/34558755
http://dx.doi.org/10.1111/ene.15121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293282/
https://www.ncbi.nlm.nih.gov/pubmed/34558755
http://dx.doi.org/10.1111/ene.15121

Ejemplares similares